Results 11 to 20 of about 571,282 (185)
Method for the Intraoperative Detection of IDH Mutation in Gliomas with Differential Mobility Spectrometry. [PDF]
Isocitrate dehydrogenase (IDH) mutation status is an important factor for surgical decision-making: patients with IDH-mutated tumors are more likely to have a good long-term prognosis, and thus favor aggressive resection with more survival benefit to ...
Haapala I +12 more
europepmc +5 more sources
Detection of IDH mutation in glioma by desorption electrospray ionization (DESI) tandem mass spectrometry. [PDF]
Desorption electrospray ionization (DESI) tandem mass spectrometry (MS) is used to assess mutation status of isocitrate dehydrogenase (IDH) in human gliomas.
Shahi M +5 more
europepmc +3 more sources
Preoperative MRI enhancement grade for adult diffuse glioma affects IDH mutation and WHO grade
Objective To analyze the clinical features and magnetic resonance imaging (MRI) features of adult diffuse glioma, define the preoperative MRI enhancement grade (ET grade) of the disease, and explore the relationship of ET grade with isocitrate ...
CAO Yujuan, YAO Xiaohong
core +2 more sources
idh-1 neomorphic mutation confers sensitivity to vitamin B12 in Caenorhabditis elegans
In humans, a neomorphic isocitrate dehydrogenase mutation (idh-1neo) causes increased levels of cellular D-2-hydroxyglutarate (D-2HG), a proposed oncometabolite.
Ponomarova, Olga +5 more
core +2 more sources
IDH mutation prediction in non-enhancing gliomas with relaxed T2-FLAIR mismatch and fractal dimension: a two-center study. [PDF]
Background To explore the relationship between relaxed T2-FLAIR mismatch (RT2FM) sign, fractal dimension (FD) of tumor contour and IDH mutation status, and construct models for IDH mutation prediction in non-enhancing gliomas.
Han Y +5 more
europepmc +2 more sources
Objectives: Regarding the 2021 World Health Organization (WHO) classification of central nervous system (CNS) tumors, the isocitrate dehydrogenase (IDH) mutation status is one of the most important factors for CNS tumor classification.
Manoj Mannil +6 more
core +2 more sources
Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan‐cancer analysis
Background Isocitrate dehydrogenase (IDH) is an enzyme family involved in cell aerobic metabolism of tricarboxylic acid cycle. However, the landscape of IDH mutations in pan‐cancer has not been fully characterized.
Dong Shen +11 more
doaj +1 more source
Mutation of the telomerase reverse transcriptase (TERT) promoter has been demonstrated as an unfavorable prognostic marker in patients with isocitrate dehydrogenase wild-type (IDHwt) glioma.
Mengqi Gao +12 more
doaj +1 more source
To explore the value of contrast-enhanced CT texture analysis in predicting isocitrate dehydrogenase (IDH) mutation status of intrahepatic cholangiocarcinomas (ICCs). Institutional review board approved this study.
Yong Zhu +6 more
doaj +1 more source
Contralesional Structural Plasticity in Different Molecular Pathologic Subtypes of Insular Glioma
Neuroplasticity may preserve neurologic function in insular glioma, thereby improving prognosis following resection. However, the anatomic and molecular bases of this phenomenon are not known.
Zhenxing Huang +13 more
doaj +1 more source

